Moderna stock has dropped along with demand for a product that once drove tremendous growth: the coronavirus vaccine.

Despite positive results from a Phase I/II trial of its investigational pandemic influenza vaccine, mRNA-1018, Moderna’s ...

The U.S. Food and Drug Administration has approved a new lower-dose vaccine for active immunization against COVID-19 caused ...

In a crucial development, the FDA has approved Moderna's new COVID-19 vaccine designed specifically for high-risk Americans.

Under Kennedy, US health agencies have taken steps to limit who can get Covid vaccines, arguing there’s a lack of evidence ...

In a precedential decision issued June 4, 2025, the U.S. Court of Appeals for the Federal Circuit (CAFC) affirmed a district ...

The new vaccine is indicated for individuals who have been previously vaccinated with any COVID-19 vaccine and are 65 years or older, or 12 to 64 years of age with at least 1 underlying condition that ...

People on low-calorie diets scored higher for symptoms of depression, compared with those not dieting, researchers reported.

Children born to women who are obese have a higher risk of landing in a hospital with a severe infection, a new study says.

Alnylam Pharmaceuticals Inc. won’t get another chance at its patent infringement suit against Moderna Inc. over its mRNA Covid-19 vaccine, a federal appeals court ruled Wednesday.

Moderna had already started a Phase 1/2 trial of its bird flu (H5N1) vaccine and reported strong early results.